Identification of serologic biomarkers for predicting microvascular invasion in hepatocellular carcinoma

Microvascular invasion (MVI) of hepatocellular carcinoma (HCC) is a major risk factor for early recurrence and poor survival after curative surgical therapies. However, MVI can only be diagnosed by pathological examination following resection. The aim of this study is to identify serologic biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yuan-Quan, Wang, Liang, Jin, Yun, Zhou, Jia-Le, Geng, Yan-Hua, Jin, Xing, Zhang, Xiao-Xiao, Yang, Jun-Jie, Qian, Cheng-Ming, Zhou, Dong-Er, Liu, Da-Ren, Peng, Shu-You, Luo, Yan, Zheng, Lei, Li, Jiang-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941320/
https://www.ncbi.nlm.nih.gov/pubmed/26918350
http://dx.doi.org/10.18632/oncotarget.7649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941320/
https://www.ncbi.nlm.nih.gov/pubmed/26918350
http://dx.doi.org/10.18632/oncotarget.7649

Ejemplares similares